Form 4 for ANVS Annovis Bio, Inc.
Accepted 2025-09-03 00:00:00 ET · period of report 2025-08-29 · accession 0001104659-25-087077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-09-03 | 2025-08-29 | ANVS | Hoffman Michael B | Dir | A - Grant | $2.29 | +15.0K | 1.47M | +1% | +$34.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-29 | A | A | 5,000 | $2.30 | 1,479,929 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-29 | A | A | 5,000 | $2.29 | 1,474,929 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-29 | A | A | 5,000 | $2.28 | 1,469,929 | D | — | — |